BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18347063)

  • 1. Cell-type-specific function of BCL9 involves a transcriptional activation domain that synergizes with beta-catenin.
    Sustmann C; Flach H; Ebert H; Eastman Q; Grosschedl R
    Mol Cell Biol; 2008 May; 28(10):3526-37. PubMed ID: 18347063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL9-2 binds Arm/beta-catenin in a Tyr142-independent manner and requires Pygopus for its function in Wg/Wnt signaling.
    Hoffmans R; Basler K
    Mech Dev; 2007 Jan; 124(1):59-67. PubMed ID: 17113272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure analysis of the PHD domain of the transcription co-activator Pygopus.
    Nakamura Y; Umehara T; Hamana H; Hayashizaki Y; Inoue M; Kigawa T; Shirouzu M; Terada T; Tanaka A; Padmanabhan B; Yokoyama S
    J Mol Biol; 2007 Jun; 370(1):80-92. PubMed ID: 17499269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin-dependent acetylation of Pygo2 by CBP/p300 histone acetyltransferase family members.
    Andrews PG; Kao KR
    Biochem J; 2016 Nov; 473(22):4193-4203. PubMed ID: 27647933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cytoplasmic role of Wnt/β-catenin transcriptional cofactors Bcl9, Bcl9l, and Pygopus in tooth enamel formation.
    Cantù C; Pagella P; Shajiei TD; Zimmerli D; Valenta T; Hausmann G; Basler K; Mitsiadis TA
    Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells.
    de la Roche M; Worm J; Bienz M
    BMC Cancer; 2008 Jul; 8():199. PubMed ID: 18627596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development.
    Cantù C; Zimmerli D; Hausmann G; Valenta T; Moor A; Aguet M; Basler K
    Genes Dev; 2014 Sep; 28(17):1879-84. PubMed ID: 25184676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex.
    Kramps T; Peter O; Brunner E; Nellen D; Froesch B; Chatterjee S; Murone M; Züllig S; Basler K
    Cell; 2002 Apr; 109(1):47-60. PubMed ID: 11955446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of a beta-catenin/BCL9/Tcf4 complex.
    Sampietro J; Dahlberg CL; Cho US; Hinds TR; Kimelman D; Xu W
    Mol Cell; 2006 Oct; 24(2):293-300. PubMed ID: 17052462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.
    Vafaizadeh V; Buechel D; Rubinstein N; Kalathur RKR; Bazzani L; Saxena M; Valenta T; Hausmann G; Cantù C; Basler K; Christofori G
    Oncogene; 2021 Oct; 40(43):6195-6209. PubMed ID: 34545187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.
    Brack AS; Murphy-Seiler F; Hanifi J; Deka J; Eyckerman S; Keller C; Aguet M; Rando TA
    Dev Biol; 2009 Nov; 335(1):93-105. PubMed ID: 19699733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling.
    Cho IT; Lim Y; Golden JA; Cho G
    PLoS One; 2017; 12(1):e0170282. PubMed ID: 28103279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in
    Cantù C; Felker A; Zimmerli D; Prummel KD; Cabello EM; Chiavacci E; Méndez-Acevedo KM; Kirchgeorg L; Burger S; Ripoll J; Valenta T; Hausmann G; Vilain N; Aguet M; Burger A; Panáková D; Basler K; Mosimann C
    Genes Dev; 2018 Nov; 32(21-22):1443-1458. PubMed ID: 30366904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo.
    Mosimann C; Hausmann G; Basler K
    Cell; 2006 Apr; 125(2):327-41. PubMed ID: 16630820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
    Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
    Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy.
    Brown TC; Nicolson NG; Korah R; Carling T
    J Am Coll Surg; 2018 Jun; 226(6):988-995. PubMed ID: 29428231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the N-terminal activation domain of the coiled-coil coactivator in mediating transcriptional activation by beta-catenin.
    Yang CK; Kim JH; Stallcup MR
    Mol Endocrinol; 2006 Dec; 20(12):3251-62. PubMed ID: 16931570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tumor-Suppressor WWOX and HDAC3 Inhibit the Transcriptional Activity of the β-Catenin Coactivator BCL9-2 in Breast Cancer Cells.
    El-Hage P; Petitalot A; Monsoro-Burq AH; Maczkowiak F; Driouch K; Formstecher E; Camonis J; Sabbah M; Bièche I; Lidereau R; Lallemand F
    Mol Cancer Res; 2015 May; 13(5):902-12. PubMed ID: 25678599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.